Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
Clinical trial NCT04397653 · UNKNOWN
Trial details
- NCT number
- NCT04397653
- Sponsor
- Policlinico Casilino ASL RMB
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-04
- Primary completion
- 2020-11-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.